TalkMed: Proposed Privatization and Delisting Plans Unveiled
Deal News | Dec 23, 2024 | Goodwin
Goodwin, a renowned international law firm, is advising TW Troy Limited on its proposed acquisition of TalkMed Group Limited, a premier healthcare provider in Singapore listed on the Singapore Exchange. The acquisition aims to privatize TalkMed via a scheme of arrangement, adhering to Singaporean legal standards. TW Troy is a special purpose vehicle under Tamarind Health, a pan-Asian oncology group controlled by Templewater. Templewater is an alternative asset manager concentrating on private equity in the Asia Pacific and global decarbonisation investments. As part of the transaction, 65 Equity Partners, a Temasek-backed firm, will contribute to Tamarind Health's shareholder base. The transaction's goal is to transform TalkMed into a private entity, thereby allowing it to pivot more strategically in the demanding oncology industry.
Sectors
- Healthcare & Medical Services
- Private Equity
- Investment Management
Geography
- Singapore – TalkMed Group Limited is based in Singapore, as are Tamarind Health's headquarters and the involved investment activities.
- Hong Kong – Templewater, the controlling firm of Tamarind Health, is based in Hong Kong.
- Asia Pacific – The transaction involves multiple parties and assets across the Asia Pacific region, including Singapore, Hong Kong, Malaysia, and the Philippines.
Industry
- Healthcare & Medical Services – TalkMed Group Limited operates within the healthcare sector, providing specialized medical services such as oncology and palliative care.
- Private Equity – The involvement of Templewater and 65 Equity Partners signifies engagement from the private equity sector, focused on acquiring and optimizing healthcare assets.
- Investment Management – Templewater and 65 Equity Partners are both investment management entities, facilitating strategic financial transactions and investments in healthcare.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| TalkMed Group Limited | Target company | Company | A publicly listed provider of specialized medical services such as oncology and palliative care in Singapore. |
| TW Troy Limited | Bidding company | Company | A special purpose vehicle set up for acquiring TalkMed, wholly owned by Tamarind Health. |
| Tamarind Health Limited | Buyer parent company | Company | A pan-Asian oncology-focused group, controlled by Templewater. |
| Templewater | Private equity firm | Company | An alternative asset manager specializing in private equity and global decarbonisation investments. |
| 65 Equity Partners | Investor | Company | An investment firm backed by Temasek, investing in Tamarind Health as part of the TalkMed transaction. |
| Goodwin | Legal advisor | Company | International law firm advising TW Troy on its acquisition of TalkMed. |